BMSSC
LLY icon

B. Metzler seel. Sohn & Co’s Eli Lilly LLY Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154M Buy
128,222
+5,652
+5% +$5.77M 1.33% 19
2026
Q1 		$113M Buy
122,570
+2,054
+2% +$2.08M 1.05% 21
2025
Q4 		$130M Sell
120,516
-19,277
-14% -$18.4M 1.13% 20
2025
Q3 		$107M Buy
139,793
+30,582
+28% +$22.8M 0.94% 24
2025
Q2 		$85.1M Buy
109,211
+19,774
+22% +$15.4M 0.81% 25
2025
Q1 		$73.9M Buy
89,437
+13,493
+18% +$11.2M 0.76% 25
2024
Q4 		$58.6M Sell
75,944
-20,959
-22% -$17.4M 0.6% 30
2024
Q3 		$85.8M Sell
96,903
-11,095
-10% -$9.97M 0.85% 24
2024
Q2 		$97.8M Buy
107,998
+8,030
+8% +$6.42M 0.94% 18
2024
Q1 		$77.8M Sell
99,968
-13,359
-12% -$9.51M 0.86% 26
2023
Q4 		$66.1M Sell
113,327
-11,603
-9% -$6.77M 0.84% 22
2023
Q3 		$67.1M Buy
124,930
+2,127
+2% +$1.1M 1.01% 16
2023
Q2 		$57.6M Buy
122,803
+2,986
+2% +$1.25M 0.78% 19
2023
Q1 		$41.1M Sell
119,817
-2,068
-2% -$697K 0.64% 27
2022
Q4 		$44.6M Sell
121,885
-7,470
-6% -$2.65M 0.76% 27
2022
Q3 		$41.8M Sell
129,355
-2,031
-2% -$643K 0.76% 25
2022
Q2 		$42.6M Sell
131,386
-2,058
-2% -$618K 0.7% 25
2022
Q1 		$38.2M Buy
133,444
+4,591
+4% +$1.18M 0.51% 39
2021
Q4 		$35.7M Buy
128,853
+22,368
+21% +$5.67M 0.46% 44
2021
Q3 		$24.6M Sell
106,485
-2,412
-2% -$595K 0.36% 47
2021
Q2 		$25M Buy
108,897
+7,357
+7% +$1.48M 0.37% 47
2021
Q1 		$19M Buy
101,540
+9,333
+10% +$1.83M 0.31% 53
2020
Q4 		$15.8M Buy
+92,207
New +$13.8M 0.29% 63

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

B. Metzler seel. Sohn & Co's LLY Position: Q2 2026 in Review

B. Metzler seel. Sohn & Co increased its Eli Lilly (LLY) stake by 4.6% in Q2 2026, buying an estimated $5.77M and bringing the position to 128,222 shares worth $154M. The position accounts for 1.33% of the portfolio, ranked #19.

B. Metzler seel. Sohn & Co first reported a position in LLY in Q4 2020 and has held it in 23 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • B. Metzler seel. Sohn & Co held 128,222 shares of Eli Lilly worth $154M as of Q2 2026.
  • B. Metzler seel. Sohn & Co bought 5,652 Eli Lilly shares in Q2 2026, an estimated $5.77M.
  • Eli Lilly made up 1.33% of B. Metzler seel. Sohn & Co's portfolio in Q2 2026, its #19 holding.
  • B. Metzler seel. Sohn & Co first reported a position in Eli Lilly in Q4 2020 and has held it in 23 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q2 2026, filed 11 Aug 2026.